Senate panel to scrutinize proposed Bayer-Monsanto merger
Tuesday, September 20, 2016 - 04:01
in Health & Medicine
The Senate is taking a closer look at a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer.